Evidence map›Paper›PMID 34804730›Full record

ReviewCureus2021

Saudi Honey: A Promising Therapeutic Agent for Treating Wound Infections.

Abdulrahman S Bazaid, Abdu Aldarhami, Hattan Gattan, Bakheet Aljuhani

Abstract readReview
In one paragraph

Review in Cureus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Novel Antibacterial Agents 2022.Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Antimicrobial Potential ofBioMed research international · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Abdulrahman S BazaidClinical Laboratory Sciences, College of Applied Medical Sciences, University of Hail, Hail, SAU.
Abdu AldarhamiMedical Microbiology, Qunfudah Faculty of Medicine, Umm Al-Qura University, Al-Qunfudah, SAU.
Hattan GattanMedical Laboratory Sciences, King Abdulaziz University, Jeddah, SAU.
Bakheet AljuhaniMedical Laboratory Sciences, University of Hail, Hail, SAU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treatment of wounds, especially chronic ones, is a major challenge in healthcare, with serious clinical and economic burdens. Multiple treatment approaches, including the usage of silver and iodine, have dramatically improved wound healing and reduced the incidence of infection. However, once infected by drug-resistant bacteria, treatment of wounds becomes a serious complication, with limited availability of effective antibiotic drugs, leading to high morbidity and mortality. Therefore, alternative therapeutic agents are required to address this gap in wound management. The introduction of manuka honey as a therapeutic agent against infected wounds was the result of extensive research about its activity against both planktonic and biofilm bacterial growth. Likewise, several types of Saudi honey (e.g., Sidr and Talh) showed promising in vitro and in vivo antimicrobial activity against wound pathogens. This short review summarizes literature that investigated the activity of common types of Saudi honey in relation to wound infections and explores their clinical utility.

Indexed as

alternative therapiesantimicrobial resistancemanuka honeysaudi honeywounds infections

Identifiers

PMID34804730
PMCPMC8599116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.